← FDA Drug Approvals (Drugs@FDA)

UNITENSEN

NDA · New Drug Application · Sponsor: MEDPOINTE PHARM HLC

Drug application

FDA Application #

NDA009217

Application type

New Drug Application

Brand name

UNITENSEN

Generic name

Cryptenamine Tannates

Active ingredients

CRYPTENAMINE TANNATES

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

MEDPOINTE PHARM HLC

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown